OBJECTIVES: Severe cases of infective endocarditis (IE) of the aortic valve can cause aortic root destruction and affect the surrounding structures, including the aortic-mitral continuity, the anterior mitral valve leaflet and the roof of the left atrium. Reconstruction after resection of all infected tissue remains challenging. We describe our surgical approach and the mid-term results.
INTRODUCTION
Infective endocarditis (IE) presents a complex disease with inhospital mortality rates ranging from 15% to 30% despite optimal antimicrobal and surgical therapy [1] . The prognosis is especially poor when periannular involvement, signs of heart failure and/or prosthetic valve endocarditis are present [1] . In cases of uncontrolled infection with progressive destruction of the adjacent structures and abscess formation urgent surgical intervention is indicated [1] . In particular, uncontrolled IE of the aortic valve can cause destruction of the aortic root and, subsequently, the aortic-mitral continuity and the mitral valve. Infection of the aortic-mitral continuity has been reported in 10.6% of cases of left-sided IE [2] and in 47.1% of patients with aortic root abscess [3] . In cases of left-sided double valve IE, aortic-mitral continuity reconstruction is needed in 28% [4] . This indicates that direct extension of the infective process is responsible for destruction of the mitral valve in a significant number of cases.
Independent of the extent of the disease, excision of all infected tissue is the cornerstone of surgical therapy for IE [1] . This is followed by reconstruction of all resected structures. Previously, double valve replacement with aortic-mitral continuity reconstruction has been described for cases of extensive IE of the aortic root with concomitant infection of the aortic-mitral continuity and the mitral valve [5] . Even in experienced centres such extensive surgical intervention is associated with a poor prognosis and the early mortality rate ranges from 10% to 32% [2, [5] [6] [7] [8] . Surgical intervention, however, remains the only curative treatment option for most patients in this highly complex patient group. It has previously been demonstrated that in patients undergoing aortic valve surgery concomitant mitral valve repair rather than replacement is associated with improved long-term survival [9] . However, it is unclear whether a mitral valve sparing approach is an alternative for replacement in patients with extensive IE of the aortic root with involvement of the mitral valve.
In recent years, we have developed a surgical approach that allows preservation of the native mitral valve in such cases of extensive IE. The body of the anterior mitral valve leaflet, the aortic-mitral continuity and the roof of the left atrium are reconstructed with pericardial patches and ring annuloplasty, followed by aortic valve or, preferably, root replacement. The aim of this study is to describe our surgical approach and assess the shortand mid-term safety and efficacy of this procedure.
PATIENTS AND METHODS

Study design
The study population consisted of all patients who underwent surgery for active IE of the aortic root with concomitant infection of the aortic-mitral continuity and the mitral valve between January 2004 and December 2015. By definition, this also included patients with previously replaced or repaired mitral valves. The study was approved by our Institutional Ethics Committee.
Clinical, operative and early outcome data were collected in our computerized database. Follow-up clinical and echocardiography data were collected in our outpatient clinic or by contacting the referring physicians and cardiologists, and/or by direct telephonic contact with the patients. Survival follow-up was 100% complete with a median follow-up time of 29.8 months [interquartile range (IQR) 6.4-62.9]. Follow-up on valve-related events was 94% complete. Recent echocardiography was available in 89% of patients with a median follow-up time of 26.2 months (IQR 7.4-70.2). Follow-up was closed on 7 March 2016.
Study end-points
Data are reported according to the 2008 joint Society of Thoracic Surgeons, American Association for Thoracic Surgery and European Association for Cardio-Thoracic Surgery Guidelines for reporting mortality and morbidity after cardiac valve interventions [10] .
Surgical technique
All patients were operated through median (re-)sternotomy using standard techniques for extracorporeal circulation with double venous cannulation. Moderate systemic hypothermia, with a target core body temperature of 32 C, was used. Antegrade warm blood cardioplegia was used for cardioprotection in all cases and re-administered every 15-20 min. The aortic valve and all macroscopically infected tissues were carefully removed and sent for microbacterial culture. This included all infected parts of the aortic annulus, the roof of the left atrium, the aortic-mitral continuity and all infected parts of the mitral valve (usually the anterior part of the mitral valve annulus and the body of the anterior mitral valve leaflet; Fig. 1A-D) . The operative area was rinsed with a rifampicin solution. Reconstruction of the resected structures was performed with pericardial patch material ( Table 1 ). The mitral valve was reconstructed or replaced transseptally or, in most cases, through the roof of the left atrium/left ventricular outflow tract opening. If the free edge of the anterior mitral valve leaflet was intact and no infection of other parts of the mitral valve was present, an annuloplasty ring was first implanted in the remaining mitral valve annulus (typically from commissure to commissure). To determine the appropriate annuloplasty ring size, a sizer was placed on the remaining part of the mitral valve annulus with the intertrigonal distance serving as a guide for optimal size. The defect in the body of the anterior mitral valve leaflet was reconstructed using a pericardial patch, all the way up to the anterior part of the annuloplasty ring ( Fig. 2A and B) . This patch was sewn in with a 5-0 polypropylene suture. The size of the patch was created in such a way that the newly reconstructed anterior mitral valve leaflet would roughly cover the implanted ring. For this reason, precise ring sizing is not crucial; in most cases (50%) we selected a ring size 32 mm as that is the most prevalent size of the mitral valve in the Dutch population. In case of more extensive involvement of the mitral valve (destruction of the free edge or commissural involvement), the valve was excised. The sutures for the prosthetic mitral valve were placed in the remainder of the mitral valve annulus, usually covering twothirds to three-quarters of the prosthesis. Next, a folded pericardial patch was sutured with its fold to the annuloplasty ring (or valve in case of valve replacement), creating a double patch (Fig.  2C ). After unfolding, one part of the patch was used to reconstruct the roof of the left atrium and the other part to reconstruct the aortic-mitral continuity and the left ventricular outflow tract (typically from the former commissure between the left and noncoronary cusp all the way to the middle of the right coronary sinus; Fig. 2D and E), using 4-0 polypropylene sutures. In most patients, the aortic root was then reconstructed with an aortic root prosthesis ( 
Pre-and postoperative care
IE was diagnosed according to the modified Duke criteria [11] . Empiric intravenous antibiotic therapy was initiated at the time of diagnosis; after causative pathogen identification this was adjusted accordingly (Table 2 ). Intravenous antibiotic therapy was administered for at least 48 h prior to surgery to ensure blood stream sterilization. Two (6%) patients, however, underwent operation within 48 h of antibiotic therapy initiation due to rapid hemodynamic deterioration. Additionally, 2 patients received no preoperative antibiotic therapy as the diagnosis of active IE was established intraoperatively.
Postoperatively, pathogen specific intravenous antibiotic therapy was continued for a minimal duration of 6 weeks. Standard antithrombotic management consisted of oral anticoagulation for 3 months after surgery with a target international normalized ratio of 2.0-3.0. In patients with atrial fibrillation or a mechanical prosthesis in the aortic position, oral anticoagulation was continued indefinitely. In patients with a mechanical prosthesis in the mitral position, a target international normalized ratio range of 2.5-3.5 was applied.
Statistical analysis
Continuous data are presented as means ± standard deviation for normally distributed and medians with IQR for skewed data. Categorical data are presented as counts and percentages.
GENERAL ADULT CARDIAC
Freedom from time-related events was estimated using the Kaplan-Meier method. To assess the influence of our initial experience on the quality and durability of the procedure, we divided our study cohort in consecutive overlapping subgroups of 15 patients. In each subgroup, the freedom from reintervention was assessed individually using the Kaplan-Meier method. The results are presented graphically. Statistical analysis was performed using SPSS version 23.0 (IBM Corp., Armonk, NY, USA).
RESULTS
Demographic characteristics
Demographic characteristics of all 35 patients and details on the extent of the disease are shown in Table 2 . Prosthetic valve endocarditis was seen in the majority of patients (74%). One patient underwent elective surgery and the diagnosis of low-grade prosthetic valve endocarditis was made intraoperatively. All other patients underwent urgent or emergent surgery. Most common indications for surgical intervention were evidences of uncontrolled infection and/or prevention of peripheral embolization. Four patients were in critical preoperative state. Preoperative peripheral embolization was seen in 5 patients: 3 cases to the brain and 2 to the spleen. Median EuroSCORE II was 18.0% (IQR 11.0-26.7).
Intraoperative details
Details on the surgical procedures performed are shown in Table 1 . Aortic root replacement, with or without replacement of the ascending aorta, was performed in 32 (91%) cases. Three patients underwent aortic valve replacement. Of the 35 patients, 4 patients had previously undergone mitral valve surgery: 2 previous repairs and 2 replacements. One patient underwent a rerepair while the other 3 underwent valve replacement. Of the 31 patients with no history of previous mitral valve surgery, 27 (87%) underwent valve repair and 4 (13%) valve replacement.
Operative mortality and morbidity
There were 8 (23%) early deaths; 3 patients (9%) died intraoperatively and 5 (14%) patients died during the early postoperative period ( Table 2 ). All early deaths occurred in patients with prosthetic valve endocarditis; in-hospital mortality occurred in 2/4 patients in critical preoperative state. All intraoperative deaths were caused by uni-or biventricular failure with failure to wean from cardiopulmonary bypass. Uncontrolled bleeding was additionally present in 1. Other cases of early mortality were caused by multiple organ dysfunction syndrome caused by profound postoperative cardiogenic and/or distributive shock. Early mortality in the first and last 15 patients of the study cohort was 33% and 13%, respectively. Postoperative complications are presented in Table 2 . Mechanical circulatory support was needed in 5 patients (4 of these died in the early postoperative period). Surgical reexploration and postoperative acute kidney failure were seen in 4 (13%) and 10 (31%) patients, respectively.
Late mortality
During the follow-up period 5 additional deaths occurred, 2 within the first year after the operation. The 1-, 2-and 5-year survival rates were 69.4% [95% confidence interval (CI) 53.0-86.0%], 65.3% (95% CI 48.0-82.0%) and 65.3 (95% CI 48.0-82.0%), respectively (Fig. 3) . The cause of death was valve-related (following operated valve reintervention) in 1 patient, heart failure in 3 patients and unknown in 1 patient.
Infective endocarditis recurrence
No relapses or early recurrences of IE were seen. In 2 patients, late IE (29 months and 74 months after surgery) occurred. The first patient presented with echocardiographic evidence of IE (vegetations on both the aortic and mitral valve). The risk for operation was considered too high due to comorbidities and the high-risk of reoperation. The second patient presented without echocardiographic observations suggestive for IE and the diagnosis was established by modified Duke criteria. The patient responded promptly to antibiotic therapy and due to the high-risk of re-re-reoperation no surgical intervention was performed. Both patients were alive at follow-up.
Reintervention
Seven of the 27 hospital survivors underwent reintervention during the follow-up period (Table 3) . Freedom from reintervention rate at 1-, 2-and 5-years was 84.6% (95% CI 68.0-100.0%), 78.9% (95% CI 60.0-97.0%) and 51.2% (95% CI 23.0-80.0%), respectively (Fig. 4) . Within the first 15 hospital survivors of our series, reintervention was needed in 6 (mean follow-up: 82.5 ± 47.3 months; mean time to reoperation: 25.9 ± 16.5 months). In the last 15 hospital survivors, reintervention was needed in 1 [median followup: 9.6 months (IQR: 4.0-34.6); 89 days after initial operation].
Following mitral valve repair, 5 patients underwent mitral valve reintervention. In 4 patients, recurrent MR was the primary indication for reoperation and in 2 of these no ring annuloplasty was performed during the initial operation. Paravalvular leak of the aortic valve was the primary indication for reoperation in the remaining patient. Mitral valve replacement was concomitantly performed due to the presence of moderate MR. Two out of 3 patients who underwent aortic valve replacement during the initial operation needed reoperation due to the occurrence of a significant paravalvular leak. An annuloplasty ring is implanted in the remaining posterior mitral valve annulus (typically from commissure to commissure) and the defect in the body of the anterior leaflet is reconstructed using a pericardial patch (A and B). A folded pericardial patch is sutured to the annuloplasty ring (or mitral valve prosthesis in case of valve replacement), creating a double patch (C). This is later used to reconstruct the roof of the left atrium, the aortic-mitral continuity, and left ventricular outflow tract (D and E). Lastly, an aortic root prosthesis is implanted (F). For further explanation, please see the according text.
Echocardiographic follow-up
In patients who underwent mitral valve repair and did not undergo valve reintervention (n = 18), the latest echocardiography demonstrated none or mild MR in 14 (82%) and moderate MR in 3 (18%).
Late clinical outcome
Three thromboembolic events (2 transient ischemic attacks and 1 cerebrovascular accident) and no major bleeding events occurred. At most recent follow-up, 18 (86%) patients were in New York Heart Association (NYHA) class I and 3 (14%) in NYHA class II. 
DISCUSSION
In this study, we describe a single-centre experience with patients suffering from extensive IE of the aortic root with concomitant infection of the aortic-mitral continuity and the mitral valve. Moreover, we describe a surgical technique that allows preservation of the native mitral valve when the destructive process is limited to the body of the anterior leaflet of the mitral valve, as is the case in many instances. The data presented demonstrate that mitral valve repair is feasible even in very severe cases of IE. The early mortality rate of 23% seen in our series is comparable with mortality rates previously reported in similar cohorts [2, 7, 8] . This high early mortality rate reflects the presence of various risk factors, including prosthetic valve endocarditis, non-elective operation setting and critical preoperative state. During the course of the study, a decline in the early mortality rate was observed. We reason that this is a result of growing single-centre experience and consequent improvements in the surgical technique and perioperative care. Following weaning from cardiopulmonary bypass, ventricular failure was often seen. This might reflect the long period of cardioplegic arrest, which is inevitable in these patients. Preoperatively, impaired left ventricular function was present in 63% of patients from the early mortality group. The limited number of patients and events, however, prevents further analysis of these observations.
As in other series, a large proportion of our patient cohort (74%) had prosthetic valve endocarditis [2, 7, 8] . The extent of the disease in these patients reflects a delay in the diagnosis and treatment of IE after the initial onset of symptoms. Consequently, patients are referred for surgery when the infectious process has already advanced considerably. This observation emphasizes again that the awareness for IE in patients with prosthetic heart valves is mandatory to allow early intervention, prior to the development of extensive destruction of the surrounding structures [1] .
We standardly utilize rigorous resection of all infected tissue in all cases of IE. A high proportion of patients needed reconstruction of cardiac structures beyond the aortic valve or root: i.e. the aortic-mitral continuity, the roof of the left atrium and the mitral valve. This finding has not been reported uniformly by others [2, 7] . More extensive resection is partially responsible for the extensive aortic cross-clamp and cardiopulmonary bypass times observed in our cohort. However, we have been able to avoid bleeding complications related to poor patch anchoring in infection-ridden and devitalized tissues, previously described in 12% of cases; all such events resulted in intraoperative death [7] . Several studies have shown that residues or early recurrences of IE are a common complication in this patient group [2, 4, 6, 7] . Interestingly, in our experience this was not observed. Radical resection of all macroscopically infected structures combined with rinsing the operative area with rifampicin might provide sufficient protection from the occurrence of residual IE despite a large amount of prosthetic material implanted.
Following resection of all infected tissues, several options to reconstruct the aortic root are available. We have previously described our experience with the Medtronic Freestyle stentless porcine bioprosthesis (Medtronic, Inc, Minneapolis, MN, USA) in such cases [12] . This prosthesis was used in 17 (49%) patients in this study cohort with satisfactory results; it currently presents our standard choice in these patients. Standard aortic valve replacement was performed in 3 patients; 2 of these developed a Table 3 clinically significant paravalvular leak and underwent reoperation. In the presence of an aortic root abscess, aortic root replacement, as advocated by the European guidelines [1] , seems justified. During the study period, we have systematically utilized mitral valve repair despite the presence of an extensive infectious process. Mitral valve repair was deemed impossible when the infection proceeded to include more than only the anterior portion of the valve. Ring annuloplasty provides annular stabilization and serves as a guide for the appropriate size of the pericardial patch needed to reconstruct the anterior mitral valve leaflet. However, a significant proportion of patients undergoing valve repair needed reintervention due to recurrent MR. All mitral valve reinterventions occurred during our early experience with this procedure. Several risk factors might have predisposed to the high reintervention rate during this period. First, ring annuloplasty was not performed in 2 patients who later underwent mitral valve reintervention. Second, in 8 patients, untreated autologous pericardial tissue -commonly used early in our experience-was used to reconstruct the anterior mitral valve leaflet; 3 of these patients later underwent reintervention. Untreated autologous pericardium however, appeared to be prone to tissue degeneration that resulted in patch retraction and valve dysfunction. We currently utilize pretreated decellularized bovine pericardium when performing this procedure; superior handling and improved durability are of particular benefit in this setting. In the absence of these risk factors good valve repair durability was established.
Our data suggest that growing single-centre experience importantly impacts the clinical outcome of this patient group, known for high early morbidity, mortality and reintervention rates [2, 8] . This makes us believe that these patients should be presented to an experienced endocarditis team early in the course of the disease. We currently utilize an aggressive approach and tend to proceed with surgical intervention as soon as blood stream sterilization is secured. In most patients, prosthetic valve endocarditis was present and conservative management alone is unlikely to result in full recovery. Moreover, further progression of tissue destruction could make mitral valve repair impossible.
Study limitations
This is a retrospective single-centre study with a limited number of patients. However, our study included the biggest cohort of such extensive cases of active IE reported up-to-date. We included only patients with active IE to ensure a homogenous patient population. Due to limited number of patients and events, we have not been able to directly compare clinical outcomes of patients who underwent mitral valve repair rather than replacement. The assumed clinical benefits of mitral valve repair are based on the available literature. Nevertheless, the presented surgical technique is a reasonable alternative in cases of extensive IE with acceptable early and late outcomes.
CONCLUSION
IE of the aortic root with extension into the aortic-mitral continuity and the mitral valve remains a complex disease with high mortality and morbidity rates. To ensure optimal prognosis, early referral to experienced centres is mandatory. The described reconstructive technique allows mitral valve preservation when the destructive process is limited to the anterior part of the valve. Provided that radical resection of all infected tissue is performed, the risk of early IE recurrence is low. However, surgery is technically challenging, reflected in our experience by a significant number of reinterventions. Nevertheless, a technically sound procedure will result in a satisfactory result with good valve repair durability.
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